Skip to main content
. 2002 Feb;46(2):413–419. doi: 10.1128/AAC.46.2.413-419.2002

TABLE 3.

Potencies of gemifloxacin and comparator quinolones in stabilizing the cleavable complex with gyrase and topoisomerase IV

Quinolone CC25 (μM) for DNA breakage
Gyrase
Topoisomerase IV
Wild type GyrA Phe-81 mutation Wild type ParC Phe-79 mutation
Gemifloxacin 2.5 160 0.1-0.3 10-20
Moxifloxacin 10 160-320 2.5-5 160
Gatifloxacin 10-20 160-320 5-10 80-160
Levofloxacin 20-40 >640 5-10 >320
Ciprofloxacin 40 >640 2.5-5 >160